DILH
JAZZ icon

Dai-ichi Life Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Dai-ichi Life Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7,649
Closed -$1.02M – 561
2015
Q3 		$1.02M Buy
7,649
+234
+3% +$40.3K 0.03% 411
2015
Q2 		$1.31M Buy
7,415
+92
+1% +$16.5K 0.04% 385
2015
Q1 		$1.26M Sell
7,323
-742
-9% -$127K 0.04% 402
2014
Q4 		$1.32M Buy
8,065
+428
+6% +$71K 0.04% 386
2014
Q3 		$1.23M Sell
7,637
-152
-2% -$23.4K 0.04% 390
2014
Q2 		$1.15M Sell
7,789
-153
-2% -$21.2K 0.04% 388
2014
Q1 		$1.1M Buy
+7,942
New +$1.2M 0.03% 378

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

Dai-ichi Life Holdings's JAZZ Position: Q4 2015 in Review

Dai-ichi Life Holdings sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2015, closing a stake of 7,649 shares — an estimated $1.02M sold.

Dai-ichi Life Holdings first reported a position in JAZZ in Q1 2014 and held it in 7 quarters. The position peaked at $1.32M in Q4 2014. 345 funds tracked by Wall St. Rank hold JAZZ as of Q4 2015.

  • Dai-ichi Life Holdings reported no remaining Jazz Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 7,649 Jazz Pharmaceuticals shares in Q4 2015, an estimated $1.02M.
  • Dai-ichi Life Holdings first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 7 quarters.
  • Dai-ichi Life Holdings's Jazz Pharmaceuticals position peaked at $1.32M in Q4 2014.
  • 345 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2015.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2015, filed 10 Feb 2016.